Trial Profile
Study of the Effect of Vildagliptin on Glucagon Counterregulation Response During Hypoglycemia in Patients With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 01 Aug 2012 Results published in the Journal of Clinical Endocrinology and Metabolism.
- 04 Jul 2012 Status changed from recruiting to completed, based on results presented at ADA.
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.